İçeriğe geç

Francesco Bertoni

@frbertoni.bsky.social did:plc:am3g2x2ua4npyujnygdinh32

Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma

Bluesky’a katılma tarihi:

Takipçi
130
Takip edilen
190
Post
65
Sıralamaya girdiği gün
0

Özet

Francesco Bertoni (@frbertoni.bsky.social), 15 Nisan 2025 tarihinde katılan bir Bluesky kullanıcısı. 130 takipçisi var, 190 hesabı takip ediyor ve 65 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Shannon Buckley, Francesco Bertoni, and Justin Taylor discussed "Degraders in Lymphoma" during a plenary session at the AACR Conference on Advances in Malignant Lymphoma. #AACRlymphoma26 @frbertoni.bsky.social

    Postu göster
  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Degraders in Lymphoma: Shannon Buckley, Francesco Bertoni, and Justin Taylor will address this topic in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/XH3lbfr #AACRlymphoma26 @frbertoni.bsky.social

    Postu göster
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

    Postu göster
  • International Conference on Malignant Lymphoma@icmlugano.bsky.social

    Yesterday we had our first 19-ICML Local Organising Committee meeting — the behind-the-scenes work for the next edition has officially begun! 💥 @frbertoni.bsky.social #19ICML #ICML #lymphoma #CLL #myeloma #lymssm

    Postu göster
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.